Maravai Lifesciences Holdings, Inc.

Case Overview
Status: | Status: Investigating |
Company Name: | Company Name: Maravai Lifesciences Holdings, Inc. |
Ticker: | Ticker: MRVI |
Related Attorneys: | Lead Attorneys: Thomas W. Elrod |
Related Practices: | Related Practices: Securities |
The law firm of Kirby McInerney LLP is investigating potential claims against Maravai Lifesciences Holdings, Inc. (“Maravai” or the “Company”) (NASDAQ:MRVI). The investigation concerns whether Maravai and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices.
On February 25, 2025, Maravai postponed its Q4 and FY24 earnings release and delayed filing its Form 10-K. The Company attributed the delay to internal control issues, along with a potential goodwill impairment and a revenue recognition error. On this news, the price of Maravai shares declined by $0.87 per share, or approximately 21%, from $4.01 per share on February 24, 2025, to close at $3.14 on February 25, 2025.
On February 25, 2025, Maravai postponed its Q4 and FY24 earnings release and delayed filing its Form 10-K. The Company attributed the delay to internal control issues, along with a potential goodwill impairment and a revenue recognition error. On this news, the price of Maravai shares declined by $0.87 per share, or approximately 21%, from $4.01 per share on February 24, 2025, to close at $3.14 on February 25, 2025.